Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2024	Paul Bolno	CEO	Sell	50,000	$15.00	$750,000.00	217,351
11/15/2024	Paul Bolno	CEO	Sell	51,234	$14.32	$733,670.88	217,351
11/8/2024	Chris Francis	insider	Sell	36,000	$16.00	$576,000.00
10/16/2024	Chris Francis	insider	Sell	208,836	$13.67	$2,854,788.12
10/16/2024	Paul Bolno	CEO	Sell	90,474	$15.00	$1,357,110.00	268,585
9/27/2024	Plc Gsk	Major Shareholder	Buy	2,791,930	$8.00	$22,335,440.00	16,775,691
9/25/2024	Kyle Moran	CFO	Sell	17,146	$9.00	$154,314.00	19,777
8/21/2024	Paul Bolno	CEO	Sell	48,366	$5.78	$279,555.48	359,059
4/3/2024	Kyle Moran	CFO	Sell	15,630	$6.17	$96,437.10	33,921
12/11/2023	Ra Capital Management, L.P.	Director	Buy	1,000,000	$5.00	$5,000,000.00	19,202,009
8/23/2023	Kyle Moran	CFO	Sell	37,062	$4.75	$176,044.50	46,120
2/16/2023	Chandra Vargeese	Insider	Sell	10,249	$4.03	$41,303.47	106,624
2/16/2023	Kyle Moran	CFO	Sell	9,729	$4.04	$39,305.16	79,751
2/16/2023	Paul Bolno	CEO	Sell	29,400	$4.04	$118,776.00	407,425
6/16/2022	Ra Capital Management, L.P.	Director	Buy	9,480,052	$2.15	$20,382,111.80	17,202,009
5/5/2022	Chandra Vargeese	Insider	Sell	16,714	$1.72	$28,748.08	111,095
5/5/2022	Kyle Moran	CFO	Sell	5,021	$1.72	$8,636.12	84,567
5/5/2022	Paul Bolno	CEO	Sell	33,501	$1.72	$57,621.72	436,825
2/16/2022	Chandra Vargeese	CTO	Sell	10,603	$2.32	$24,598.96
2/16/2022	Chris Francis	Insider	Sell	10,123	$2.31	$23,384.13
2/16/2022	Kyle Moran	CFO	Sell	9,204	$2.31	$21,261.24
2/16/2022	Paul Bolno	CEO	Sell	33,150	$2.32	$76,908.00

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment

From Behind the Markets | Ad

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Wave Life Sciences (NASDAQ:WVE)

89.73% of Wave Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Wave Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	93,096	$0.81M	0.0%	-2.4%	0.061%
11/19/2024	Barclays PLC	159,241	$1.31M	0.0%	+171.1%	0.104%
11/16/2024	Geode Capital Management LLC	2,269,664	$18.62M	0.0%	+14.3%	1.488%
11/15/2024	Barclays PLC	159,241	$1.31M	0.0%	+171.1%	0.128%
11/15/2024	Y Intercept Hong Kong Ltd	29,559	$0.24M	0.0%	-57.0%	0.024%
11/15/2024	Orion Portfolio Solutions LLC	14,941	$0.12M	0.0%	N/A	0.012%
11/15/2024	XTX Topco Ltd	15,334	$0.13M	0.0%	N/A	0.012%
11/15/2024	Jane Street Group LLC	142,014	$1.17M	0.0%	+33.3%	0.114%
11/15/2024	Wellington Management Group LLP	315,502	$2.59M	0.0%	-26.3%	0.253%
11/15/2024	Weiss Asset Management LP	20,000	$0.16M	0.0%	N/A	0.016%
11/15/2024	State Street Corp	2,321,248	$19.03M	0.0%	+2.6%	1.861%
11/15/2024	RTW Investments LP	900,000	$7.38M	0.1%	N/A	0.722%
11/15/2024	Point72 DIFC Ltd	11,958	$98K	0.0%	N/A	0.010%
11/15/2024	Point72 Asset Management L.P.	28,096	$0.23M	0.0%	-75.7%	0.023%
11/15/2024	Polar Asset Management Partners Inc.	486,023	$3.99M	0.1%	N/A	0.390%
11/15/2024	Maven Securities LTD	850,000	$6.97M	0.1%	N/A	0.681%
11/15/2024	Ikarian Capital LLC	544,265	$4.46M	0.6%	-5.4%	0.436%
11/15/2024	Jacobs Levy Equity Management Inc.	104,526	$0.86M	0.0%	-71.5%	0.084%
11/15/2024	Cinctive Capital Management LP	356,308	$2.92M	0.2%	+255.7%	0.286%
11/15/2024	Baker BROS. Advisors LP	344,063	$2.82M	0.0%	N/A	0.276%
11/14/2024	Maverick Capital Ltd.	10,047,520	$82.39M	1.6%	+31.0%	8.055%
11/14/2024	PDT Partners LLC	74,967	$0.62M	0.1%	-16.0%	0.060%
11/14/2024	Walleye Capital LLC	602,441	$4.94M	0.0%	N/A	0.483%
11/14/2024	Martingale Asset Management L P	111,199	$0.91M	0.0%	+25.6%	0.089%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	144,718	$1.19M	0.0%	-15.4%	0.116%
11/13/2024	Glenmede Trust Co. NA	39,075	$0.32M	0.0%	+71.1%	0.031%
11/13/2024	BNP Paribas Financial Markets	41,828	$0.34M	0.0%	+477.7%	0.034%
11/13/2024	FMR LLC	1,540,190	$12.63M	0.0%	+174.5%	1.235%
11/13/2024	The Manufacturers Life Insurance Company	168,141	$1.38M	0.0%	+20.3%	0.135%
11/12/2024	Charles Schwab Investment Management Inc.	844,617	$6.93M	0.0%	+209.1%	0.677%
11/9/2024	Primecap Management Co. CA	2,580,700	$21.16M	0.0%	-3.1%	2.069%
11/9/2024	Intech Investment Management LLC	23,704	$0.19M	0.0%	N/A	0.019%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	325,009	$2.67M	0.0%	-4.3%	0.261%
11/5/2024	GSA Capital Partners LLP	63,513	$0.52M	0.0%	+14.9%	0.051%
11/2/2024	Privium Fund Management B.V.	48,834	$0.40M	0.1%	N/A	0.039%
10/30/2024	James J. Burns & Company LLC	100,111	$0.82M	0.1%	+11.2%	0.082%
10/29/2024	Emerald Advisers LLC	2,881,510	$23.63M	0.9%	+15.6%	2.353%
10/29/2024	Emerald Mutual Fund Advisers Trust	2,123,466	$17.41M	0.9%	+16.6%	1.734%
10/28/2024	US Bancorp DE	18,043	$0.15M	0.0%	+53.9%	0.015%
10/25/2024	China Universal Asset Management Co. Ltd.	23,991	$0.20M	0.0%	+66.7%	0.020%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	4,512	$37K	0.0%	+23.4%	0.004%
10/23/2024	Moody Aldrich Partners LLC	303,062	$2.49M	0.5%	+69.0%	0.247%
10/3/2024	SG Americas Securities LLC	36,563	$0.30M	0.0%	-72.7%	0.030%
8/19/2024	Point72 Asset Management L.P.	115,478	$0.58M	0.0%	-94.2%	0.094%
8/16/2024	Driehaus Capital Management LLC	908,096	$4.53M	0.0%	+62.2%	0.728%
8/15/2024	Susquehanna Fundamental Investments LLC	18,744	$94K	0.0%	-71.4%	0.015%
8/15/2024	Mackenzie Financial Corp	15,887	$79K	0.0%	+13.6%	0.013%
8/15/2024	The Manufacturers Life Insurance Company	139,790	$0.70M	0.0%	+3.6%	0.112%
8/15/2024	Millennium Management LLC	1,664,300	$8.31M	0.0%	+1.8%	1.334%
8/15/2024	Maverick Capital Ltd.	7,669,361	$38.27M	0.7%	-0.2%	6.148%
8/15/2024	AQR Capital Management LLC	33,529	$0.17M	0.0%	+26.3%	0.027%
8/15/2024	Affinity Asset Advisors LLC	375,000	$1.87M	0.2%	+30.9%	0.301%
8/14/2024	Marshall Wace LLP	62,102	$0.31M	0.0%	-80.2%	0.050%
8/14/2024	ProShare Advisors LLC	17,410	$87K	0.0%	-20.0%	0.014%
8/14/2024	Profund Advisors LLC	10,625	$53K	0.0%	N/A	0.009%
8/13/2024	M28 Capital Management LP	6,164,548	$30.76M	39.9%	-11.9%	4.942%
8/13/2024	Sei Investments Co.	26,095	$0.13M	0.0%	N/A	0.021%
8/12/2024	Hsbc Holdings PLC	21,444	$0.10M	0.0%	N/A	0.017%
8/9/2024	Primecap Management Co. CA	2,664,216	$13.29M	0.0%	-7.4%	2.175%
8/6/2024	Emerald Advisers LLC	2,493,230	$12.44M	0.5%	N/A	2.036%
8/6/2024	Emerald Mutual Fund Advisers Trust	1,820,938	$9.09M	0.5%	N/A	1.487%
8/3/2024	TD Asset Management Inc	183,946	$0.92M	0.0%	-27.0%	0.150%
8/1/2024	Rhumbline Advisers	125,834	$0.63M	0.0%	+3.4%	0.103%
7/29/2024	Principal Financial Group Inc.	14,766	$74K	0.0%	N/A	0.012%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	33,491	$0.17M	0.0%	+75.2%	0.027%
7/26/2024	Bank of New York Mellon Corp	225,402	$1.13M	0.0%	+13.9%	0.184%
7/17/2024	James J. Burns & Company LLC	90,000	$0.45M	0.1%	N/A	0.073%
7/13/2024	Kraematon Investment Advisors Inc.	19,000	$95K	0.1%	-13.6%	0.016%
7/12/2024	SG Americas Securities LLC	133,827	$0.67M	0.0%	N/A	0.109%
5/17/2024	Artal Group S.A.	4,051,400	$25M	0.6%	+34.7%	3.308%
5/17/2024	Ikarian Capital LLC	590,088	$3.64M	0.4%	N/A	0.482%
5/16/2024	Jacobs Levy Equity Management Inc.	241,860	$1.49M	0.0%	+13.9%	0.198%
5/15/2024	Bellevue Group AG	4,094,458	$25.26M	0.4%	-8.9%	3.344%
5/15/2024	Price T Rowe Associates Inc. MD	1,861,254	$11.49M	0.0%	+14.4%	1.520%
5/15/2024	M28 Capital Management LP	7,000,000	$43.19M	31.9%	-5.1%	5.723%
5/15/2024	Affinity Asset Advisors LLC	286,585	$1.77M	0.2%	N/A	0.234%
5/14/2024	Platinum Investment Management Ltd.	600,155	$3.70M	0.1%	-8.4%	0.491%
5/14/2024	American International Group Inc.	36,241	$0.22M	0.0%	+23.3%	0.030%
5/13/2024	Ameritas Investment Partners Inc.	7,334	$45K	0.0%	+50.2%	0.006%
5/10/2024	Vanguard Group Inc.	1,834,090	$11.32M	0.0%	+39.7%	1.499%
5/8/2024	ProShare Advisors LLC	21,764	$0.13M	0.0%	+35.0%	0.018%
5/7/2024	Susquehanna Fundamental Investments LLC	65,565	$0.41M	0.0%	N/A	0.054%
5/7/2024	Swiss National Bank	156,500	$0.97M	0.0%	+2.7%	0.128%
5/3/2024	GSA Capital Partners LLP	95,037	$0.59M	0.0%	N/A	0.078%
5/1/2024	Capstone Investment Advisors LLC	54,500	$0.34M	0.0%	+9.0%	0.045%
4/29/2024	China Universal Asset Management Co. Ltd.	23,473	$0.15M	0.0%	+104.9%	0.019%
3/5/2024	Wellington Management Group LLP	274,093	$1.38M	0.0%	+3.5%	0.277%
2/26/2024	Virtu Financial LLC	34,432	$0.17M	0.0%	N/A	0.035%
2/16/2024	Public Employees Retirement System of Ohio	12,600	$64K	0.0%	N/A	0.013%
2/15/2024	Birchview Capital LP	40,000	$0.20M	0.2%	N/A	0.040%
2/14/2024	Platinum Investment Management Ltd.	655,331	$3.31M	0.1%	+43.9%	0.662%
2/13/2024	Tower Research Capital LLC TRC	11,335	$57K	0.0%	+461.4%	0.011%
2/13/2024	James J. Burns & Company LLC	65,049	$0.33M	0.1%	+96.8%	0.066%
2/12/2024	Capstone Investment Advisors LLC	50,000	$0.25M	0.0%	N/A	0.050%
2/12/2024	Monashee Investment Management LLC	103,300	$0.52M	0.1%	N/A	0.104%
2/12/2024	M28 Capital Management LP	7,373,413	$37.24M	30.8%	+4.7%	7.444%
2/12/2024	TD Asset Management Inc	205,746	$1.04M	0.0%	+26.5%	0.208%
2/9/2024	Primecap Management Co. CA	3,759,408	$18.99M	0.0%	-0.6%	3.795%
2/9/2024	Oxford Asset Management LLP	10,045	$51K	0.1%	N/A	0.010%
2/9/2024	Trexquant Investment LP	32,119	$0.16M	0.0%	N/A	0.032%

Data available starting January 2016

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Today's Range

Now: $13.41

$13.02

$13.49

50 Day Range

MA: $14.41

$8.56

$16.44

52 Week Range

Now: $13.41

$3.50

$16.74

Volume

354,405 shs

Average Volume

1,114,859 shs

Market Capitalization

$2.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Wave Life Sciences?: Wave Life Sciences' top insider shareholders include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Chandra Vargeese (Insider)
Kyle Moran (CFO)
Chris Francis (Insider)
Learn More about top insider investors at Wave Life Sciences.
Who are the major institutional investors of Wave Life Sciences?: Wave Life Sciences' top institutional shareholders include:
Maverick Capital Ltd. — 8.05%
Emerald Advisers LLC — 2.35%
Primecap Management Co. CA — 2.07%
State Street Corp — 1.86%
Geode Capital Management LLC — 1.49%
Emerald Mutual Fund Advisers Trust — 1.73%
Learn More about top institutional investors of Wave Life Sciences stock.
Which major investors are selling Wave Life Sciences stock?: In the previous quarter, WVE stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Wellington Management Group LLP
SG Americas Securities LLC
Point72 Asset Management L.P.
Primecap Management Co. CA
Y Intercept Hong Kong Ltd
Ikarian Capital LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
During the previous year, company insiders that have sold Wave Life Sciences company stock include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Learn More investors selling Wave Life Sciences stock.
Which major investors are buying Wave Life Sciences stock?: Within the previous quarter, WVE stock was bought by institutional investors including:
Maverick Capital Ltd.
FMR LLC
RTW Investments LP
Maven Securities LTD
Walleye Capital LLC
Charles Schwab Investment Management Inc.
Polar Asset Management Partners Inc.
Emerald Advisers LLC
Within the previous year, these company insiders have bought Wave Life Sciences stock:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Learn More investors buying Wave Life Sciences stock.

A.I. Trading System Helps Some Traders Pocket $1,100 per DAY!

From Prosper Trading Academy | Ad

What if I told you 60 seconds a day could completely change your life?

This AI-powered trading system finds high-probability option trades in less than 60 seconds a day

Click HERE to access this powerful AI Trading System

WVE Insider Trading

Wave Life Sciences Insider Trading History Chart

Wave Life Sciences Share Price & Price History

Wave Life Sciences Insider Trading History